FDA Clears Clobazam Oral Film (Sympazan) for Lennox-Gastaut

Share this post

The FDA has approved an oral film formulation of clobazam for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients aged 2 years and older.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply